You have 9 free searches left this month | for more free features.

Positive Peritoneal Cytology

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Surgery
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Endometrial Cancer Trial in York (surgical staging)

Recruiting
  • Endometrial Cancer
  • surgical staging
  • York, Pennsylvania
    Wellspan Health
Jun 2, 2022

Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • Seattle, Washington
    Virginia mason medical Center
Jul 19, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 12, 2022

Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Carcinomatosis
  • Houston, Texas
    M D Anderson Cancer Center
Aug 7, 2023

Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

Recruiting
  • Cervix Cancer
  • +2 more
  • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
  • Randers, Central Denmark Region, Denmark
    Department of Pathology
Feb 3, 2023

Papilloma-induced Cervical Lesions Trial in Scorrano (EGCG, FA, HA, B12)

Enrolling by invitation
  • Papilloma-induced Cervical Lesions
  • EGCG, FA, HA, B12
  • Scorrano, Lecce, Italy
    Ospedale Veris delli Ponti
Oct 24, 2023

Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Odense

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
    • Odense, Denmark
      Odense University Hospital
    Jun 5, 2022

    Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)

    Active, not recruiting
    • Diseases of Oesophagus Stomach and Duodenum
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 7, 2022

    Gastric Cancer, Peritoneal Metastases, Chemo Effect Trial in London (Doxorubicin and Cisplatin)

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • Doxorubicin and Cisplatin
    • London, United Kingdom
      Imperial College London, Hammersmith Hospital Campus
    Apr 1, 2022

    Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Trial in Beijing (Niraparib)

    Recruiting
    • Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Nov 15, 2023

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • New Orleans, Louisiana
    • +3 more
    Dec 16, 2022

    High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

    Not yet recruiting
    • High Grade Ovarian Cancer
    • +2 more
    • (no location specified)
    Jul 11, 2022

    Stomach Tumor, Peritoneal Carcinomatosis Trial in Amsterdam (Cytoreductive surgery + Gastrecomy, Hyperthermic Intraperitoneal

    Recruiting
    • Stomach Neoplasm
    • Peritoneal Carcinomatosis
    • Cytoreductive surgery + Gastrecomy
    • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek/ Netherlands Cancer institute
    Feb 14, 2022

    Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

    Completed
    • Advanced Epithelial Ovarian
    • +3 more
    • Basking Ridge, New Jersey
    • +5 more
    Mar 4, 2022

    Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

    Recruiting
    • Ovarian Cancer
    • +2 more
    • mirvetuximab soravtansine (MIRV; IMGN853)
    • Birmingham, Alabama
      University of Alabama at Birmingham Womens & Infants Center
    Jun 30, 2022

    Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Indocyanine green
    • Montréal, Quebec, Canada
    • +1 more
    Jan 8, 2023

    Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal

    Not yet recruiting
    • Metastatic Pancreatic Carcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Tumor in the Peritoneum Trial in

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +8 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 2, 2023

    Peritoneum; Carcinomatosis, Peritoneal Tumors, Peritoneal Metastases Trial in Odense (PIPAC)

    Completed
    • Peritoneum; Carcinomatosis
    • +6 more
    • Odense, Denmark
      Department of Surgery, Odense University Hospital
    Oct 5, 2022

    Oligometastatic Gastric Adenocarcinoma Trial in Verona (FOLFOX and PIPAC)

    Recruiting
    • Oligometastatic Gastric Adenocarcinoma
    • FOLFOX and PIPAC
    • Verona, Italy
      AOUI Verona
    Jul 19, 2022

    Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant Trial in Chengdu (Dual-targeting HER2 and PD-L1 CAR-T cells)

    Active, not recruiting
    • Peritoneal Carcinoma Metastatic
    • Pleural Effusion, Malignant
    • Dual-targeting HER2 and PD-L1 CAR-T cells
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Sep 21, 2021

    Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in

    Active, not recruiting
    • Gastric and Pancreatic Cancer
    • washings for experimental marker testing
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 1, 2021